Dong L, Lin S, Zhong L, Nian D, et al. Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis. Clin Breast Cancer 2021 Jun 12. pii: S1526-8209(21)00146.
PMID: 34238670